2013International Journal of Fermented FoodsRequires access

Commercial sources of probiotic strains and their validated and potential health benefits : a review

Kasipathy Kailasapathy

Open publisher page 15 citations

Abstract

In the recent past, a number of probiotic strains have been screened and selected for incorporation into commercial functional food products. Some of these strains have been validated for specific health benefits through human clinical trials others have been documented as offering potential health benefits. In the past commercial probiotic strains were selected for their technological properties, however, in the recent past, validated health benefits have assumed much greater importance. This review includes the characteristics of genus Bifidobacteriaand Lactobacillus and other microbes that are currently considered as probiotic organisms, selection criteria employed to screen them as effective probiotic strains, their validated and potential health benefits documented. In the recent screening and selection of strains for probiotic efficacy a change in focus from having technological properties to offering validated health benefits may allow the strains to lose their technological properties including the ability to survive both food processing and gastrointestinal environment. Further, different food matrices may have different interactions with probiotic bacterial cells and hence validated human health benefits cannot be generalised for all food matrices as vehicles for administration and delivery.

About this research paper

What this paper is about

In the recent past, a number of probiotic strains have been screened and selected for incorporation into commercial functional food products. Some of these strains have been validated for specific health benefits through human clinical trials others have been documented as offering potential health benefits. In the past commercial probiotic strains were selected for their technological properties, however, in the recent past, validated health benefits have assumed much greater importance. This review includes the characteristics of genus Bifidobacteriaand Lactobacillus and other microbes that are currently considered as probiotic organisms, selection criteria employed to screen them as effective probiotic strains, their validated and potential health benefits documented. In the recent screening and selection of strains for probiotic efficacy a change in focus from having technological properties to offering validated health benefits may allow the strains to lose their technological properties including the ability to survive both food processing and gastrointestinal environment. Further, different food matrices may have different interactions with probiotic bacterial cells and hence validated human health benefits cannot be generalised for all food matrices as vehicles for administration and delivery.

Why it matters

OpenAlex reports 15 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

In the recent past, a number of probiotic strains have been screened and selected for incorporation into commercial functional food products. Some of these strains have been validated for specific health benefits through human clinical trials others have been documented as offering potential health benefits. In the past commercial probiotic strains were selected for their technological properties, however, in the recent past, validated health benefits have assumed much greater importance. This review includes the characteristics of genus Bifidobacteriaand Lactobacillus and other microbes that are currently considered as probiotic organisms, selection criteria employed to screen them as effective probiotic strains, their validated and potential health benefits documented. In the recent screening and selection of strains for probiotic efficacy a change in focus from having technological properties to offering validated health benefits may allow the strains to lose their technological properties including the ability to survive both food processing and gastrointestinal environment. Further, different food matrices may have different interactions with probiotic bacterial cells and hence validated human health benefits cannot be generalised for all food matrices as vehicles for administration and delivery.

Key concepts: Probiotic, Health benefits, Human health, Biotechnology, Functional food, Selection (genetic algorithm), Biology, Business

Related papers

Back to paper searchBrowse research topicsOriginal source
Commercial sources of probiotic strains and their validated and potential health benefits : a review — Research Paper | ScholarLens